Turnover of domestic pharmaceutical firms up 8% in first quarter

The combined turnover of the 22 major domestic pharmaceutical firms (except for Korea Green Cross, Chong Kun Dang Corp., and Chong Kun Dang Bio) in the first quarter of this year marked 629.9 billion won, representing a sluggish growth rate of 8.71 percent from the same period of last year, according to a survey conducted by Yakup Shinmoon. Market observers say that their sluggish turnover rate...